Clinical Trials Logo

Filter by:
NCT ID: NCT04042623 Terminated - IgA Nephropathy Clinical Trials

Study of Safety and Efficacy of AVB-S6-500 in Patients With IgA Nephropathy

Start date: November 27, 2019
Phase: Phase 2
Study type: Interventional

This is an open-label Phase 2a clinical study designed to evaluate the safety and efficacy of AVB-S6-500 in patients with IgA Nephropathy (IgAN). Approximately 24 patients will be enrolled. Several dose levels of AVB-S6-500 may be evaluated.

NCT ID: NCT04042480 Terminated - Colorectal Cancer Clinical Trials

A Study of SGN-CD228A in Advanced Solid Tumors

Start date: September 3, 2019
Phase: Phase 1
Study type: Interventional

This trial will study SGN-CD228A to find out whether it is an effective treatment for different kinds of cancer. It will also look at what side effects (unwanted effects) may occur. The study will have two parts. Part 1 of the study will find out how much SGN-CD228A should be given for treatment and how often. Part 2 of the study will use the dose found in Part 1 and look at how safe and effective the treatment is.

NCT ID: NCT04041908 Terminated - Compliance, Patient Clinical Trials

Use of a Medical Food in Adults Undergoing Surgery

Start date: March 13, 2020
Phase: N/A
Study type: Interventional

Multi-center, prospective, one arm study to evaluate the addition of a medical food to the standard of care in elderly adults undergoing a surgical procedure.

NCT ID: NCT04041037 Terminated - Pilonidal Disease Clinical Trials

The Management of Pilonidal Wounds With ACell MicroMatrix® and Cytal® Wound Matrix: A Case Series

Start date: March 26, 2019
Phase:
Study type: Observational

A case series involving the concomitant use of MicroMatrix® and Cytal® Wound Matrix 2-Layer with standard of care negative pressure wound therapy (NPWT) during the management of pilonidal wound healing.

NCT ID: NCT04040985 Terminated - Clinical trials for Osteo Arthritis Knee

Legion Primary Safety and Efficacy

Start date: September 9, 2009
Phase: N/A
Study type: Interventional

This study will look at the health results of using the LEGION™ Primary Knee System over a period of ten (10) years. This type of surgery uses an artificial knee made of plastic and metal. This study will enter subjects who suffer from a variety of conditions that have caused at least one of their knees to become nonfunctional. You are being asked to participate in the study because you have significant problems with your knee(s) and your study surgeon has determined that your knee(s) must be surgically replaced to improve your condition. If you decided to participate in this study, you will be one of approximately one hundred thirty-eight (138) subjects in the study.

NCT ID: NCT04040400 Terminated - Brain Metastases Clinical Trials

Study of Intraoperative Radiotherapy for Patients With Large Brain Metastases Treated With Neurosurgical Resection

Start date: October 23, 2019
Phase: N/A
Study type: Interventional

The primary purpose of this study is to establish a maximum tolerated dose (MTD) through a dose-escalation trial using intraoperative radiotherapy (IORT) following neurosurgical resection for large brain metastases, and to determine the progression-free survival rate as in the recurrence rate of treated brain metastasis.

NCT ID: NCT04040244 Terminated - Pneumonitis Clinical Trials

Exhaled Breath Analysis to Predict Risk of Symptomatic Pneumonitis

Start date: December 9, 2019
Phase: N/A
Study type: Interventional

This is a prospective pilot study investigating exhaled breath condensate analyses to quantify the variability over time of various biomarkers associated with symptomatic pneumonitis.

NCT ID: NCT04040140 Terminated - Acupressure Clinical Trials

Integrating Auricular Point Acupressure Into Real-world Nursing Practice to Manage Cancer-related Pain

Start date: October 8, 2019
Phase: N/A
Study type: Interventional

The aims of this proposal are to (1) examine the feasibility of providing a training course of Auricular Point Acupressure (APA) for clinical oncology nurses who can integrate APA into real-world nursing care settings and (2) examine the effectiveness of APA on cancer-related pain (CRP) under the usual conditions.

NCT ID: NCT04040075 Terminated - HIV-1-infection Clinical Trials

Testing the Safety and Efficacy of Commercial Drug Biktarvy in Subjects Known to Have the 184 Resistance Mutation to a Component in Biktarvy

Start date: July 1, 2019
Phase: Phase 4
Study type: Interventional

An Open-Label Study to Evaluate Switching from a Regimen of Elvitegravir/Tenofovir alafenamide/Emtricitabine/Cobicistat and Darunavir, to a Fixed-Dose Combination of Bictegravir/Tenofovir alafenamide/Emtricitabine in Virologically Suppressed HIV-1 Subjects who are known to have a I84 V/I Mutation

NCT ID: NCT04040049 Terminated - Fabry Disease Clinical Trials

A Fabry Disease Gene Therapy Study

MARVEL1
Start date: July 8, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

This is a multinational, open-label study to assess the safety and efficacy of FLT190 in up to 15 adult male participants with classical Fabry disease.